Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.
18 employees · est. 2020 · San Diego, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.
157 employees · est. 2017 · Boston, United States
Tango Therapeutics is the older company (2020 vs 2017); Tango Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Antharis Therapeutics, Inc. | Tango Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2017 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Boston, United States |
| Employees | ||
| Employees | 18 | 157 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Post Ipo Equity |
| Total Funding | ||
| Total Funding | Not tracked yet | $351.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 4 |
| Services | ||
| Services | Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development | Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients with Unmet Medical Needs, Cancer Patients, Medical Institutions, Biotech and Pharmaceutical Partners | Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Cancer Treatment, Monoclonal Antibodies, Antibody-drug Conjugates, Oncology, Therapeutic Antibodies, Inflammatory Diseases, Innovative Therapies, Biotech Acquisitions, Clinical Trials, Transformational Therapies, Unmet Medical Needs, Pioneering Research, Solid Tumor Therapy, Bispecific Antibodies | Clinical-stage, Precision Medicine, Cancer Treatment, Tumor Suppressor Targeting, Synthetic Lethality, CRISPR-based Discovery, DNA Sequencing, Immuno-oncology, Oncogenic Drivers, Immune Evasion, Functional Genomics, Drug Discovery, Targeted Therapies, Novel Drug Targets |
| Website | ||
| Website | antharistherapeutics.com | tangotx.com |
About Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antib...
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...
We will tell you when either one moves
BounceWatch watches Antharis Therapeutics, Inc. and Tango Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Antharis Therapeutics,... and Tango Therapeutics — by email.
Frequently Asked Questions
Compare Antharis Therapeutics, Inc. with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Antharis Therapeutics, Inc. on 27 Nov 2025, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
